Literature DB >> 15321900

Severe necrotising leucocytoclastic vasculitis in a patient taking bosentan.

Stefan Gasser1, Max Kuhn, Rudolf Speich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15321900      PMCID： PMC514205          DOI： 10.1136/bmj.329.7463.430

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  Bosentan therapy for pulmonary arterial hypertension.

Authors:  Lewis J Rubin; David B Badesch; Robyn J Barst; Nazzareno Galie; Carol M Black; Anne Keogh; Tomas Pulido; Adaani Frost; Sebastien Roux; Isabelle Leconte; Michael Landzberg; Gerald Simonneau
Journal:  N Engl J Med       Date:  2002-03-21       Impact factor: 91.245

2.  Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study.

Authors:  R N Channick; G Simonneau; O Sitbon; I M Robbins; A Frost; V F Tapson; D B Badesch; S Roux; M Rainisio; F Bodin; L J Rubin
Journal:  Lancet       Date:  2001-10-06       Impact factor: 79.321
  2 in total
  2 in total

1.  Retrospective analysis of the frequency of centrofacial telangiectasia in systemic sclerosis patients treated with bosentan or ilomedin.

Authors:  Sonja Hetzer; Bettina Alexandra Buhren; Holger Schrumpf; Edwin Bölke; Stephan Meller; Kai Kammers; Peter Arne Gerber; Bernhard Homey
Journal:  Eur J Med Res       Date:  2014-01-10       Impact factor: 2.175

2.  Vasculitic Neuropathy Following Exposure to a Glyphosate-based Herbicide.

Authors:  Yuichi Kawagashira; Haruki Koike; Kazuya Kawabata; Mie Takahashi; Ken Ohyama; Rina Hashimoto; Masahiro Iijima; Masahisa Katsuno; Gen Sobue
Journal:  Intern Med       Date:  2017-06-01       Impact factor: 1.271
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.